Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared dexamethasone and chlorpheniramine.
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Presence of Particulate Matter
Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.
Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.
Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)
Failed Dissolution Specifications
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
Sub-potent Drug; powder discoloration associated with decreased potency
FDA Analysis found product labeled as tejocote is actually yellow oleander, which is toxic to humans.
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.